Bellevue Life Sciences Acquisition Corp.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Certification by an exchange approving securities for listing

Notice of Effectiveness

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Bellevue Global Life Science Investors LLC: Major Shareholders

Space Summit Capital LLC: Major Shareholders

Yoo David Jin: Statement of changes in beneficial ownership of securities

Bellevue Global Life Science Investors LLC: Statement of changes in beneficial ownership of securities

Hwang Kuk Hyoun: Statement of changes in beneficial ownership of securities

Bellevue Global Life Science Investors LLC: Statement of changes in beneficial ownership of securities

Hwang Kuk Hyoun: Statement of changes in beneficial ownership of securities

Bellevue Global Life Science Investors LLC: Statement of changes in beneficial ownership of securities

Park Jin Whan: Statement of changes in beneficial ownership of securities

REED STEVEN: Statement of changes in beneficial ownership of securities

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Prospectus filed pursuant to Rule 424(b)(4)

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition